Early Commercialization of New Technologies
First written in FY2016. 11 of 24 entries say "Advanced", first in FY2019. Latest entry: 2026-08-10.
22 other companies' latest entry also says "Restated".
- 2026-08-10RestatedEarnings
「Although formal adoption progressed in some application fields, sales volumes remained small. In application fields with strong potential for mass production, including metal-ion adsorption, gas adsorption, separation membranes and electronic-component encapsulants, evaluations toward formal adoption by customers and end users are continuing.」
Formal adoption progressed in some applications, but sales volumes remained small, while evaluations toward formal adoption continued across multiple applications. - FY2026AdvancedAnnual report
「Nanosized zeolite has already been formally adopted for cosmetic and toothpaste applications, and we are shipping small volumes of product-grade nanosized zeolite.」
Nanoscale zeolite progressed from the evaluation and sample-supply stage to the stage of formal adoption for cosmetics and toothpaste applications and the start of product shipments. - FY2026-H1RestatedAnnual report
「Formal adoption of nanoscale zeolite has been decided for toothpaste and other applications. However, customer and end-user evaluations for formal adoption continue in the electronic component encapsulant and gas adsorption fields, where expectations for mass production are high. Sample supplies for new application fields, including catalyst, separation membrane, and metal-ion adsorption applications, where inquiries are increasing, also continued.」
Formal adoption was decided for toothpaste and other applications, while evaluations for formal adoption continued in electronic component encapsulants and gas adsorption applications. Sample supplies for new applications also continued. - FY2025AdvancedAnnual report
「During the fiscal year, nanoscale zeolite was formally adopted for cosmetics and toothpaste applications, and shipments of product-grade nanoscale zeolite began, albeit in small quantities.」
Nanoscale zeolite progressed from the previous evaluation and sample-supply stage to formal adoption for cosmetics and toothpaste applications and the start of shipments for use in products. - FY2025-H1RestatedAnnual report
「For nanoscale zeolite, customer and end-user evaluations for mass-production adoption are continuing, and there has been no change in the expectation that mass production will begin in fiscal 2025. As before, we have continued supplying samples with the aim of developing new customers and new application fields, including catalyst applications, while working to improve awareness of nanoscale zeolite, including through participation in trade shows.」
Evaluations for mass-production adoption, sample supplies, and trade-show participation for nanoscale zeolite continued, and there was no change in the expectation that mass production would begin in fiscal 2025. - FY2024AdvancedAnnual report
「Mass production is expected to begin in fiscal 2025. In the next fiscal year, we will supply samples and exhibit at trade shows to develop new customers and application fields, work to improve awareness of nanoscale zeolite, and improve our production technology and productivity ahead of the start of mass production.」
The start of mass production of nanoscale zeolite was specified as fiscal 2025, with plans to develop new customers and applications, supply samples, exhibit at trade shows, and improve production technology and productivity. - FY2024-Q3RestatedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, we continued to supply samples with the aim of securing mass-production customers and worked to improve awareness, including through participation in trade shows.」
Measures to improve awareness, including sample supplies and trade-show participation, continued with the aim of securing mass-production customers for nanoscale zeolite. - FY2024-Q2RestatedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, we continued to supply samples with the aim of securing mass-production customers and worked to improve awareness, including through participation in trade shows.」
Sample supplies and trade-show participation continued with the aim of securing mass-production customers for nanoscale zeolite. - FY2024-Q1RestatedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, we continued efforts to improve awareness, including supplying samples and exhibiting at trade shows, with the aim of securing mass-production customers.」
Sample supplies and trade-show participation continued with the aim of securing mass-production customers for nanoscale zeolite. Sales were limited to ¥1 million due to the absence of the previous year's pilot-plant-related contract revenue, and the segment recorded a loss of ¥42 million. - FY2023-Q3RestatedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, some customers have moved from the development stage to the end-user evaluation stage. Contract revenue related to the pilot plant was also recorded from 山全社, a business partner. As a result, sales were ¥75 million, up 559.9% year on year, and the segment recorded a loss of ¥97 million, compared with a segment loss of ¥120 million in the same period of the previous year.」
Some customers remained at the end-user evaluation stage, and contract revenue related to the pilot plant from 山全社 continued to be recorded. Sales increased to ¥75 million, but the segment continued to post a loss. - FY2023-Q2RestatedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, some customers have moved from the development stage to the end-user evaluation stage. Contract revenue related to the pilot plant was also recorded from 山全社, a business partner. As a result, sales were ¥73 million, up 687.1% year on year, and the segment recorded a loss of ¥53 million, compared with a segment loss of ¥77 million in the same period of the previous year.」
Some customers for nanoscale zeolite remained at the end-user evaluation stage, and contract revenue related to the pilot plant from 山全社 was also recorded. Sales were ¥73 million, but the segment continued to post a loss. - FY2023-Q1AdvancedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, some customers have moved from the development stage to the end-user evaluation stage. Contract revenue related to the pilot plant was also recorded from 山全社, a business partner.」
For nanoscale zeolite, some customers moved from the development stage to the end-user evaluation stage. The Materials Science business recorded sales of ¥70 million, including contract revenue related to the pilot plant. - FY2022-Q3RestatedAnnual report
「Installation of the pilot plant being developed for this business was scheduled for completion by March 2022, as originally planned.」
For nanoscale zeolite, some customers had moved to the commercialization stage, but activities overall remained centered on sample work. Although completion of the pilot plant was scheduled for March 2022, an impairment loss of ¥271 million related to the plant was also recorded during the quarter. - FY2022-Q2AdvancedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, we developed Zeoal-HQ (Zeoal Hydroquinone), which retains hydroquinone, a cosmetic ingredient, in zeolite, and are working to develop new demand. Although some customers have moved from the development stage to the commercialization stage, sales activities remained centered on sample work, and sales remained limited to small amounts related to the provision of samples and other activities.」
A new nanoscale zeolite product, Zeoal-HQ, was developed, and some customers moved from the development stage to the commercialization stage. Sales, however, remained centered on sample work and sales remained limited. - FY2022-Q1AdvancedAnnual report
「For nanoscale zeolite, which is being pursued as a new business, some customers have moved from the development stage to the commercialization stage. Overall, however, activities remained centered on sample work, and sales remained limited to small amounts related to the provision of samples and other activities.」
For nanoscale zeolite, some customers moved from the development stage to the commercialization stage. Overall, however, activities remained centered on sample work and sales remained limited. - FY2021AdvancedAnnual report
「For the commercialization of nanoscale zeolite, samples are being supplied to various companies, including those in the transparent moisture-absorbing film, adhesive, paint, antibacterial and antiviral coating, cosmetics, and healthcare fields, with the aim of securing mass-production customers during the fiscal year ending March 2022.」
Sample supplies were expanded to companies in multiple fields, and the time-bound commercialization target of securing mass-production customers during the fiscal year ending March 2022 was maintained. - FY2021-Q2AdvancedAnnual report
「We are pursuing the development of nanoscale zeolite as a new business and aim to commercialize it during the fiscal year ending March 2022, including by supplying samples to multiple companies.」
For nanoscale zeolite, sample supplies to multiple companies were advanced, and a time-bound commercialization target during the fiscal year ending March 2022 was stated. In September 2020, sales of the zeolite-blended nonwoven mask “Zeoal Ag+ Mask” also began. - FY2021-Q1ReframedAnnual report
「This segment centers on the development business for nanoscale zeolite, which is being pursued as a new business. During the three-month period ended 30 June, activities were centered on R&D, and sales remained limited to small amounts related to the provision of samples and other activities.」
It was indicated that development of nanoscale zeolite had continued as the core of the new technology business even after development of the flow synthesis system was discontinued. - FY2020-Q3DroppedAnnual report
「During the nine-month period ended 31 December, development of the flow synthesis system was discontinued in connection with the withdrawal from the contract synthesis business.」
It was explicitly stated that development of the flow synthesis system, which had been intended for early commercialization, had been discontinued in connection with the withdrawal from the contract synthesis business. - FY2019AdvancedAnnual report
「We already sell flow synthesis equipment with an automatic search function for optimal reaction conditions, developed using our proprietary fine, high-precision channel-processing technology as its foundation. Since 2016, we have conducted joint research with the National Institute of Advanced Industrial Science and Technology to develop a proprietary flow synthesis system capable of performing the entire process from raw-material extraction through synthesis and purification in a single integrated process.」
It was stated that the Group already had a track record of selling flow synthesis equipment and was advancing development of a system covering the entire process from extraction through purification. Adoption of nan zeolite under the A-STEP Stage III program was also indicated. - FY2016First statedAnnual report
「To strengthen its development structure for new products and achieve their early commercialization, our Group established the New Business Development Office on 1 October 2015 and has accelerated its R&D activities for new products toward these objectives.」
Flow synthesis equipment, fine SiC powder derived from waste sludge, and zeolite nanopowder were identified as candidates for commercialization.